Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
9.72
-0.34 (-3.38%)
At close: Aug 7, 2026, 4:00 PM EDT
9.84
+0.12 (1.25%)
After-hours: Aug 7, 2026, 7:42 PM EDT
Immix Biopharma Employees
As of December 31, 2025, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,900,820
Market Cap
691.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| Allogene Therapeutics | 152 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| Cybin | 100 |
| CytomX Therapeutics | 69 |
| AgomAb Therapeutics NV | 62 |
IMMX News
- 1 day ago - Immix Biopharma Quarterly report: Q2 2026 - Filings
- 2 days ago - IMMX Investors Have Opportunity to Join Immix Biopharma, Inc. Fraud Investigation with SBS Law - Business Wire
- 4 days ago - Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 17 days ago - Immix Biopharma initiated with a Buy at Needham - TheFly
- 18 days ago - Immix Biopharma Investigated by the Portnoy Law Firm - GlobeNewsWire
- 19 days ago - Immix Biopharma announces termination of CMO Richard Graydon - TheFly
- 19 days ago - Wanted fugitive secretly working at Immix as CMO, STAT reports - TheFly
- 5 weeks ago - Immix Biopharma Slides: Corporate presentation - Filings